Medicaid covers ketamine in limited circumstances, and coverage depends heavily on your state, your specific Medicaid plan, and what the ketamine is being used to treat

Ketamine is not automatically covered by Medicaid in all states or for all uses. The drug has FDA approval for anesthesia and, as of 2019, for treatment-resistant depression in a nasal spray form called Esketamine (Spravato). However, Medicaid programs vary by state in which uses they will pay for, and many states restrict coverage to hospital or surgical settings where ketamine is used as an anesthetic. If your doctor has prescribed ketamine for depression, pain, or another condition, you will need to contact your specific Medicaid plan to find out whether that use is covered where you live.

The fastest way to learn your coverage is to call your Medicaid plan's member services line with your plan ID number ready. Ask directly whether ketamine or Esketamine is covered for your diagnosis. If it is covered, the representative can tell you what prior authorization steps are required before treatment begins.

Key Takeaways

  • Ketamine coverage under Medicaid is not uniform across states — some cover it for depression treatment, others only for anesthesia in medical settings, and some do not cover it at all for psychiatric use.
  • Esketamine (Spravato), the FDA-approved nasal spray for treatment-resistant depression, is covered by some Medicaid programs but often requires prior authorization and proof that other antidepressants have failed.
  • Your state Medicaid program and your individual plan both determine what is covered, so calling your plan directly is the only way to know your actual coverage.
  • If your plan denies coverage, you have the right to request a reconsideration, and your doctor can submit additional clinical information to support the request.

How Medicaid coverage for ketamine varies by state

Each state runs its own Medicaid program and sets its own rules about which drugs are covered and under what conditions. Some states have explicitly added Esketamine to their Medicaid formularies — the official list of covered drugs — while others have not. A few states cover ketamine only when it is used in a hospital operating room or emergency department as an anesthetic, not when it is prescribed by a psychiatrist or pain specialist for outpatient treatment.

Your state Medicaid program's website usually publishes its formulary online, but these documents are often dense and difficult to search. A faster approach is to call your Medicaid plan directly and ask whether ketamine or Esketamine is covered for your specific diagnosis. Have your plan member ID ready when you call, and ask the representative to note in your file that you inquired about coverage. If the plan does not cover it, ask whether coverage exists in any other Medicaid managed care plan in your state that you could switch to during open enrollment.

Prior authorization requirements for Esketamine

Even in states where Esketamine is covered, Medicaid programs almost always require prior authorization — a formal approval from the plan before treatment begins. Prior authorization means your doctor must submit documentation showing that you have treatment-resistant depression and that you have already tried and failed at least two other antidepressants at adequate doses.

Your doctor's office typically handles the prior authorization request, but you should confirm they have submitted it before your first appointment at a Spravato clinic. The authorization process usually takes five to ten business days, though it can take longer if the plan requests additional information. If the plan denies the request, your doctor can appeal, and you can also request a reconsideration yourself by contacting your Medicaid plan's member services line. Do not start treatment before authorization is approved, as you may be responsible for the full cost if coverage is later denied.

What documentation you will need

If your doctor is requesting coverage for ketamine or Esketamine, have these documents ready to provide to your Medicaid plan:

  • A copy of your current diagnosis from your psychiatrist or treating physician
  • Records showing which antidepressants or other treatments you have tried and at what doses
  • Documentation of how long you took each medication and why it was stopped (side effects, lack of improvement, or other reasons)
  • Your current prescription list
  • Any prior authorization forms your doctor's office has already submitted

If your plan denies coverage, ask for the specific reason in writing. Common reasons for denial include insufficient documentation that other treatments have been tried, or a information that the treatment is experimental or not medically necessary. The written denial will explain your right to appeal and the deadline for doing so. Keep copies of all correspondence with your plan for your records.

Out-of-pocket costs if coverage is denied

If your Medicaid plan denies coverage for ketamine or Esketamine, you have several options. Esketamine treatment at a Spravato clinic typically costs between $500 and $1,500 per session out of pocket, with most treatment plans requiring two sessions per week for the first month. Some clinics offer sliding-scale fees or payment plans for uninsured or underinsured patients.

Before paying out of pocket, exhaust your appeal options with Medicaid. You can request a reconsideration, and your doctor can submit additional clinical evidence. If the plan continues to deny coverage, ask your doctor whether ketamine administered in a different setting — such as a hospital or surgical center — might be covered under your plan's anesthesia or hospital benefits, as coverage rules sometimes differ by setting. Your doctor may also know of clinical trials or research programs that offer ketamine treatment at reduced or no cost.

How to appeal a coverage denial

If your Medicaid plan denies coverage for ketamine, you have the right to request a reconsideration. The denial letter will include instructions for appealing, including a deadline — usually 30 to 60 days from the date of the denial. Do not miss this deadline, as it may prevent you from appealing later.

To appeal, you can submit a written request to your Medicaid plan's appeals department, or you can ask your doctor to submit additional clinical information on your behalf. Include any new test results, updated treatment records, or a letter from your doctor explaining why ketamine is medically necessary for your condition. Some states also allow you to request a hearing before a state official if the plan denies your appeal. Contact your state Medicaid agency directly to learn what appeal options are available in your state.

Frequently Asked Questions

Does Medicaid cover ketamine for chronic pain?

Coverage for ketamine used to treat chronic pain is rare under Medicaid. Most state programs do not cover off-label uses of ketamine outside of hospital settings. If your doctor has prescribed ketamine for pain, contact your Medicaid plan to ask about coverage, and ask whether your plan covers ketamine only in surgical or emergency settings.

What if my state Medicaid program does not cover Esketamine?

If your state does not cover Esketamine, ask your doctor whether regular ketamine administered in a hospital or surgical center might be covered under your plan's anesthesia benefits. Some patients have also found that switching to a different Medicaid managed care plan during open enrollment can change their coverage options, though this varies by state.

How long does prior authorization take?

Prior authorization for Esketamine usually takes five to ten business days, though it can take longer if the plan requests additional information from your doctor. Ask your doctor's office to check the status after one week if you have not heard back, and confirm the plan has received all required documentation.

Can I request coverage for ketamine if I have not tried other antidepressants?

Most Medicaid programs require documentation that you have tried at least two other antidepressants at adequate doses before covering Esketamine. If you have not, your doctor can still submit a request with clinical justification for why other medications are not appropriate for you, but denial is more likely.

What happens if I start treatment before prior authorization is approved?

If you begin treatment before prior authorization is approved, you risk having to pay the full cost out of pocket if the plan denies coverage. Always confirm that prior authorization has been approved before your first appointment at a Spravato clinic or ketamine treatment facility.